OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chronic migraine and Botulinum Toxin Type A: Where do paths cross?
Daniele Martinelli, Sebastiano Arceri, L Tronconi, et al.
Toxicon (2020) Vol. 178, pp. 69-76
Closed Access | Times Cited: 20
Daniele Martinelli, Sebastiano Arceri, L Tronconi, et al.
Toxicon (2020) Vol. 178, pp. 69-76
Closed Access | Times Cited: 20
Showing 20 citing articles:
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 10
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 10
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches
Daniele Martinelli, Maria Magdalena Pocora, Roberto De Icco, et al.
Toxins (2023) Vol. 15, Iss. 6, pp. 364-364
Open Access | Times Cited: 10
Daniele Martinelli, Maria Magdalena Pocora, Roberto De Icco, et al.
Toxins (2023) Vol. 15, Iss. 6, pp. 364-364
Open Access | Times Cited: 10
Migraine and Its Treatment from the Medicinal Chemistry Perspective
Ezgi Pehlivanlar, Simone Carradori, Rahime Şimşek
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 951-966
Open Access | Times Cited: 2
Ezgi Pehlivanlar, Simone Carradori, Rahime Şimşek
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 951-966
Open Access | Times Cited: 2
Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and Future Directions
Loredana Raciti, Gianfranco Raciti, David Militi, et al.
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 5
Open Access | Times Cited: 12
Loredana Raciti, Gianfranco Raciti, David Militi, et al.
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 5
Open Access | Times Cited: 12
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders
Andreas A. Argyriou, Dimos D. Mitsikostas, Elisa Mantovani, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 8, pp. 923-944
Closed Access | Times Cited: 14
Andreas A. Argyriou, Dimos D. Mitsikostas, Elisa Mantovani, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 8, pp. 923-944
Closed Access | Times Cited: 14
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Jinsha Liu, Joey Ting, Shams Al-Azzam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2805-2805
Open Access | Times Cited: 13
Jinsha Liu, Joey Ting, Shams Al-Azzam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2805-2805
Open Access | Times Cited: 13
Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury
R. Palazón García, Ana María Benavente-Valdepeñas
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4886-4886
Open Access | Times Cited: 13
R. Palazón García, Ana María Benavente-Valdepeñas
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4886-4886
Open Access | Times Cited: 13
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm
Daniele Martinelli, Sebastiano Arceri, Roberto De Icco, et al.
Cephalalgia (2021) Vol. 42, Iss. 2, pp. 170-175
Closed Access | Times Cited: 11
Daniele Martinelli, Sebastiano Arceri, Roberto De Icco, et al.
Cephalalgia (2021) Vol. 42, Iss. 2, pp. 170-175
Closed Access | Times Cited: 11
How Does Botulinum Toxin Inhibit Itch?
Parisa Gazerani
Toxins (2022) Vol. 14, Iss. 10, pp. 701-701
Open Access | Times Cited: 7
Parisa Gazerani
Toxins (2022) Vol. 14, Iss. 10, pp. 701-701
Open Access | Times Cited: 7
Beyond the Guidelines
Juliana H. VanderPluym, M. Cristina Victorio, Christopher Oakley, et al.
Neurology (2023) Vol. 101, Iss. 18, pp. 788-797
Closed Access | Times Cited: 3
Juliana H. VanderPluym, M. Cristina Victorio, Christopher Oakley, et al.
Neurology (2023) Vol. 101, Iss. 18, pp. 788-797
Closed Access | Times Cited: 3
Effectiveness, Safety, and Health-Related Quality of Life of Chronic Migraine Patients Treated with Onabotulinum Toxin A
Yeşim Beckmann, Fatma Çetin Üncü, Tülay Kurt İncesu, et al.
European Neurology (2020) Vol. 83, Iss. 5, pp. 517-522
Closed Access | Times Cited: 4
Yeşim Beckmann, Fatma Çetin Üncü, Tülay Kurt İncesu, et al.
European Neurology (2020) Vol. 83, Iss. 5, pp. 517-522
Closed Access | Times Cited: 4
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study
Calogera Butera, Ilaria Cetta, Roberta Messina, et al.
Cephalalgia Reports (2024) Vol. 7
Open Access
Calogera Butera, Ilaria Cetta, Roberta Messina, et al.
Cephalalgia Reports (2024) Vol. 7
Open Access
Botulinum toxin is a new drug for the treatment of migraine
M. I. Lastovetska, I. O. Mudryk, V. P. Maslii, et al.
Reports of Vinnytsia National Medical University (2024) Vol. 28, Iss. 4, pp. 755-759
Open Access
M. I. Lastovetska, I. O. Mudryk, V. P. Maslii, et al.
Reports of Vinnytsia National Medical University (2024) Vol. 28, Iss. 4, pp. 755-759
Open Access
Anti-cgrp Monoclonal Antibodies in Chronic Migraine Prophilaxys: Efficacy and Safety in Patients Treated With Botulinum Toxin a
Calogera Butera, Ilaria Cetta, Roberta Messina, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Calogera Butera, Ilaria Cetta, Roberta Messina, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Botulinum Toxin for Headache: a Comprehensive Review
Pei‐Pei Cheang
Current Otorhinolaryngology Reports (2020) Vol. 8, Iss. 4, pp. 369-377
Closed Access | Times Cited: 1
Pei‐Pei Cheang
Current Otorhinolaryngology Reports (2020) Vol. 8, Iss. 4, pp. 369-377
Closed Access | Times Cited: 1
Peripheral Nerve Blockade and Botox Treatment in Chronic Migraine: A Comparative Study
Adnan Burak Bilgiç, Çetin Kürşad Akpınar, Ülkü Türk Börü, et al.
Journal of Current Medical Research and Opinion (2021) Vol. 4, Iss. 03, pp. 878-885
Open Access | Times Cited: 1
Adnan Burak Bilgiç, Çetin Kürşad Akpınar, Ülkü Türk Börü, et al.
Journal of Current Medical Research and Opinion (2021) Vol. 4, Iss. 03, pp. 878-885
Open Access | Times Cited: 1
Migraine
David Moreno‐Ajona, María Dolores Villar Martínez, Calvin Chan, et al.
Elsevier eBooks (2021), pp. 548-589
Closed Access | Times Cited: 1
David Moreno‐Ajona, María Dolores Villar Martínez, Calvin Chan, et al.
Elsevier eBooks (2021), pp. 548-589
Closed Access | Times Cited: 1
Botulinum Toxin Injection for Chronic Migraine Headache
Steven D. Waldman
Elsevier eBooks (2022), pp. 91-97
Closed Access
Steven D. Waldman
Elsevier eBooks (2022), pp. 91-97
Closed Access
Uso terapêutico da toxina botulínica para o tratamento da enxaqueca crônica
Damara Zayane Barros Freitas, Raquel Bezerra de Sá de Sousa Nogueira, Milena Nunes Alves de Sousa, et al.
Revista Eletrônica Acervo Saúde (2022) Vol. 15, Iss. 11, pp. e11356-e11356
Open Access
Damara Zayane Barros Freitas, Raquel Bezerra de Sá de Sousa Nogueira, Milena Nunes Alves de Sousa, et al.
Revista Eletrônica Acervo Saúde (2022) Vol. 15, Iss. 11, pp. e11356-e11356
Open Access
